However, in the Recurrent Stroke Prevention Clinical Outcome (RESPECT) trial, intensive BP control (target < 120/80 mmHg) showed a trend toward a reduced risk of recurrent stroke compared to standard control (< 140/90 mmHg) [ 86 ].
← all excerpts
Highlights of the 2026 Korean Society of Hypertension guidelines for the management of hypertension: what's new and what has changed.
1
—
—